Harrow Health
Imprimis Pharmaceuticals is a publicly traded pharmaceutical company (Nasdaq: IMMY) based in San Diego.[1][2] It makes eye drops, compounded medicines and other products.
It manufactures a pyrimethamine and leucovorin compound which may offer a low-cost "alternative" to Daraprim, a medication which gained public attention after its price in the United States was increased by over 5,000% by Martin Shkreli and Turing Pharmaceuticals.[3][2]
References
- ^ "Imprimis Pharmaceuticals". imprimispharma.com. Impimis Pharma.
- ^ a b Bomey, Nathan (2015-10-23). "Drug company attempts $1 alternative to Daraprim". USA TODAY. Retrieved 2016-01-04.
- ^ Kroll, David. "Imprimis' Fight Against Martin Shkreli Is Part Of A Larger Battle". Forbes. Forbes Publishing Group.